Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Medical Specialties (43)
- Oncology (27)
- Medical Genetics (14)
- Diseases (13)
- Medical Immunology (13)
-
- Medical Microbiology (10)
- Medical Cell Biology (9)
- Public Health (9)
- Life Sciences (8)
- Medical Pharmacology (8)
- Surgery (6)
- Immunology and Infectious Disease (5)
- Laboratory Medicine (5)
- Parasitology (4)
- Virus Diseases (4)
- Women's Health (4)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (3)
- Biostatistics (3)
- COVID-19 (3)
- Dermatology (3)
- Hematology (3)
- Infectious Disease (3)
- Neoplasms (3)
- Pediatrics (3)
- Physical Sciences and Mathematics (3)
- Statistics and Probability (3)
- Therapeutics (3)
- Keyword
-
- COVID-19 (4)
- KSHV (4)
- SARS-CoV-2 (4)
- Kaposi’s sarcoma (3)
- Aging (2)
-
- CSCs (2)
- Chlamydia trachomatis (2)
- DNA methylation (2)
- Epigenetics (2)
- JCPyV (2)
- Melanoma (2)
- Metastasis (2)
- Notch (2)
- PI3K (2)
- Primary effusion lymphoma (2)
- Triple-negative breast cancer (2)
- Vaccination (2)
- 3-AP (1)
- 5-Hydroxymethylcytosine (1)
- AKT (1)
- Acute neutrophilic vasculitis (1)
- Acute pancreatitis (1)
- Adipose stem cells (1)
- African American (1)
- African-Americans (1)
- Aggressiveness (1)
- Alcohol (1)
- Alcohol-associated acute pancreatitis mouse model (1)
- Alcoholic Liver Disease (1)
- Amyloid (1)
- Publication Year
- Publication
Articles 61 - 61 of 61
Full-Text Articles in Medical Pathology
Ros Accumulation And Igf-Ir Inhibition Contribute To Fenofibrate/Pparalpha -Mediated Inhibition Of Glioma Cell Motility In Vitro, Justyna Drukala, Katarzyna Urbanska, Anna Wilk, Maja Grabacka, Ewa Wybieralska, Luis Del Valle, Zbigniew Madeja, Krzysztof Reiss
Ros Accumulation And Igf-Ir Inhibition Contribute To Fenofibrate/Pparalpha -Mediated Inhibition Of Glioma Cell Motility In Vitro, Justyna Drukala, Katarzyna Urbanska, Anna Wilk, Maja Grabacka, Ewa Wybieralska, Luis Del Valle, Zbigniew Madeja, Krzysztof Reiss
School of Medicine Faculty Publications
BACKGROUND: Glioblastomas are characterized by rapid cell growth, aggressive CNS infiltration, and are resistant to all known anticancer regimens. Recent studies indicate that fibrates and statins possess anticancer potential. Fenofibrate is a potent agonist of peroxisome proliferator activated receptor alpha (PPARalpha) that can switch energy metabolism from glycolysis to fatty acid beta-oxidation, and has low systemic toxicity. Fenofibrate also attenuates IGF-I-mediated cellular responses, which could be relevant in the process of glioblastoma cell dispersal. METHODS: The effects of fenofibrate on Glioma cell motility, IGF-I receptor (IGF-IR) signaling, PPARalpha activity, reactive oxygen species (ROS) metabolism, mitochondrial potential, and ATP production were …